Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Ingrid Garajová"'
Autor:
Fabiana Pratticò, Ingrid Garajová
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4241-4260 (2024)
Pancreatic ductal adenocarcinoma remains one of the most lethal solid tumors due to its local aggressiveness and metastatic potential, with a 5-year survival rate of only 13%. A robust connection between pancreatic cancer microenvironment and tumor p
Externí odkaz:
https://doaj.org/article/f73c0434dd3c4cd59f51465ea1062ad4
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9587-9601 (2023)
Pancreatic cancer (PDAC) is one of the most aggressive solid tumors and is showing increasing incidence. The aim of our review is to provide practical help for all clinical oncologists and to summarize the current management of PDAC using a simple
Externí odkaz:
https://doaj.org/article/03b1979d56c5474eb4a59885e2fc34e9
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6462-6472 (2023)
Pancreatic ductal adenocarcinoma remains associated with a poor prognosis, even when diagnosed at an early stage. Consequently, it is imperative to carefully consider the available therapeutic options and tailor them based on clinically relevant biom
Externí odkaz:
https://doaj.org/article/cfb28bea6504409da9bb601284246eb1
Autor:
Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati, Francesco Leonardi, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 2613-2624 (2023)
Background: Metastatic intrahepatic cholangiocarcinoma still has a dismal prognosis. The aim of our study was to investigate the prognostic role of bone metastases in patients affected by intrahepatic cholangiocarcinoma. Methods: A total of 186 metas
Externí odkaz:
https://doaj.org/article/42cc963495e44deba82040c19b4d747f
Autor:
Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati, Anna Mingozzi, Marianna Peroni, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli, Francesco Leonardi
Publikováno v:
Life, Vol 13, Iss 11, p 2170 (2023)
Background: The presence of actionable alterations in advanced biliary tract cancer patients opened new therapeutic possibilities for second-line treatments. However, for around 60% of the patients, chemotherapy remains the only therapeutic option. T
Externí odkaz:
https://doaj.org/article/9cbd149114394cddba536f6d8eecaa65
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 1223-1236 (2022)
Small bowel adenocarcinoma (SBA) is a rare malignancy, with a rising incidence in recent decades, and accounts for roughly 40% of all cancers of the small bowel. The majority of SBAs arise in the duodenum and are associated with a dismal prognosis. S
Externí odkaz:
https://doaj.org/article/1de3e2102e5f4f609b98fdbb560e06bd
Autor:
Ingrid Garajová, Andrea Cavazzoni, Michela Verze, Roberta Minari, Giuseppe Pedrazzi, Rita Balsano, Fabio Gelsomino, Raffaele Dalla Valle, Graziana Digiacomo, Elisa Giovannetti, Francesco Leonardi
Publikováno v:
Life, Vol 12, Iss 7, p 960 (2022)
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with rising incidence and poor prognosis. The lack of reliable prognostic biomarkers hampers the individual evaluation of the survival and recurrence potential. Metho
Externí odkaz:
https://doaj.org/article/26ee6fb0eea9480ca336f2d9c103f38b
Autor:
Francesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti, Rita Balsano, Federico Piacentini, Massimo Dominici, Fabio Gelsomino
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1, p 43 (2021)
Hepatocellular carcinoma (HCC) is the main type of liver cancer. In the majority of cases, HCC is diagnosed at the advanced stage, leading to poor prognosis. In recent years, many efforts have been devoted to investigating potential new and more effe
Externí odkaz:
https://doaj.org/article/ee2b4af0422447c7bcd37bfe2b45c3b5
Autor:
Ingrid Garajová, Manuela Ferracin, Elisa Porcellini, Andrea Palloni, Francesca Abbati, Guido Biasco, Giovanni Brandi
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 7, p 1547 (2017)
The onset and selection of resistant clones during cancer treatment with chemotherapy or targeted therapy is a major issue in the clinical management of metastatic colorectal cancer patients. It is possible that a more personalized treatment selectio
Externí odkaz:
https://doaj.org/article/a5c18eb4d4aa4bd8a5758ff8cbd194de
Publikováno v:
Tumori Journal. 108:NP30-NP33
Background: Despite ongoing developments, pancreatic cancer remains one of the most difficult tumors to treat. Even the most effective chemotherapy regimens, only marginally improve the outcome of Pancreatic cancer patients, which rarely exceeds one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8998a093afefc9d84caea373e55357a9
https://doi.org/10.1177/03008916221132589
https://doi.org/10.1177/03008916221132589